D W Johns

684 total citations
15 papers, 560 citations indexed

About

D W Johns is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, D W Johns has authored 15 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in D W Johns's work include Renin-Angiotensin System Studies (7 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Vitamin K Research Studies (4 papers). D W Johns is often cited by papers focused on Renin-Angiotensin System Studies (7 papers), Protein Hydrolysis and Bioactive Peptides (6 papers) and Vitamin K Research Studies (4 papers). D W Johns collaborates with scholars based in United States and Ireland. D W Johns's co-authors include Robert M. Carey, R. Ariel Gómez, M J Peach, Allen D. Everett, Robert L. Chevalier, Kevin R. Lynch, Tadashi Inagami, Matthew J. Gurka, M. Norman Oliver and Mark D. DeBoer and has published in prestigious journals such as Hypertension, Journal of the American Academy of Dermatology and European Journal of Pharmacology.

In The Last Decade

D W Johns

15 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D W Johns United States 10 342 256 204 81 50 15 560
J R Ingelfinger United States 10 325 1.0× 177 0.7× 193 0.9× 71 0.9× 16 0.3× 13 551
M Donatelli Italy 14 188 0.5× 157 0.6× 102 0.5× 32 0.4× 57 1.1× 43 573
B Łacka Poland 10 144 0.4× 146 0.6× 99 0.5× 46 0.6× 20 0.4× 24 424
Roberto Della Bruna Switzerland 15 480 1.4× 210 0.8× 337 1.7× 61 0.8× 15 0.3× 30 734
J. Rosenthal Germany 13 226 0.7× 168 0.7× 166 0.8× 28 0.3× 10 0.2× 38 539
B. O. Göbel Germany 13 172 0.5× 90 0.4× 204 1.0× 61 0.8× 78 1.6× 19 636
P Corvol France 11 346 1.0× 249 1.0× 207 1.0× 41 0.5× 9 0.2× 22 667
Judith H. Burrell Australia 12 175 0.5× 107 0.4× 147 0.7× 249 3.1× 21 0.4× 19 503
Shahla Riazi United States 14 127 0.4× 280 1.1× 334 1.6× 64 0.8× 19 0.4× 21 714
J. K. McKenzie Canada 12 194 0.6× 147 0.6× 173 0.8× 55 0.7× 10 0.2× 24 586

Countries citing papers authored by D W Johns

Since Specialization
Citations

This map shows the geographic impact of D W Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D W Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D W Johns more than expected).

Fields of papers citing papers by D W Johns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D W Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D W Johns. The network helps show where D W Johns may publish in the future.

Co-authorship network of co-authors of D W Johns

This figure shows the co-authorship network connecting the top 25 collaborators of D W Johns. A scholar is included among the top collaborators of D W Johns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D W Johns. D W Johns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gurka, Matthew J., et al.. (2010). Racial/ethnic discrepancies in the metabolic syndrome begin in childhood and persist after adjustment for environmental factors. Nutrition Metabolism and Cardiovascular Diseases. 22(2). 141–148. 97 indexed citations
2.
Johns, D W. (1995). Disorders of the central and autonomic nervous systems as a cause for emesis in infants.. PubMed. 4(3). 152–6. 4 indexed citations
3.
Tufro-McReddie, Alda, D W Johns, Allen D. Everett, et al.. (1994). Angiotensin II type 1 receptor: role in renal growth and gene expression during normal development. American Journal of Physiology-Renal Physiology. 266(6). F911–F918. 70 indexed citations
4.
Wilson, Barbara B., et al.. (1992). Eruptive xanthomas during pregnancy. Journal of the American Academy of Dermatology. 27(2). 300–302. 7 indexed citations
5.
Johns, D W & Nicholas Sperelakis. (1990). Angiotensin stimulates Ca2+-dependent action potentials in cultured smooth muscle cells. European Journal of Pharmacology. 187(2). 183–191. 6 indexed citations
6.
Johns, D W, M J Peach, R. Ariel Gómez, Tadashi Inagami, & Robert M. Carey. (1990). Angiotensin II regulates renin gene expression. American Journal of Physiology-Renal Physiology. 259(6). F882–F887. 85 indexed citations
7.
Gómez, R. Ariel, Kevin R. Lynch, Robert L. Chevalier, et al.. (1988). Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. American Journal of Physiology-Renal Physiology. 254(6). F900–F906. 145 indexed citations
8.
Johns, D W & M J Peach. (1988). Factors that contribute to resistant forms of hypertension. Pharmacological considerations.. Hypertension. 11(3_pt_2). II88–95. 7 indexed citations
9.
Ice, Kathleen, et al.. (1988). Cell and Molecular Studies of Renin Secretion. Clinical and Experimental Hypertension Part A Theory and Practice. 10(6). 1169–1187. 16 indexed citations
10.
Johns, D W, Robert M. Carey, R. Ariel Gómez, et al.. (1987). Isolation of renin-rich rat kidney cells.. Hypertension. 10(5). 488–496. 26 indexed citations
11.
Johns, D W, C R Ayers, & Scott C. Williams. (1984). Dilation of forearm blood vessels after angiotensin-converting-enzyme inhibition by captopril in hypertensive patients.. Hypertension. 6(4). 545–550. 20 indexed citations
12.
Johns, D W, Carlos R. Ayers, & Robert M. Carey. (1984). The Dopamine Agonist Bromocriptine Induces Hypotension by Venous and Arteriolar Dilation. Journal of Cardiovascular Pharmacology. 6(4). 582–587. 32 indexed citations
13.
Baker, Kenneth M., D W Johns, E D Vaughan, C R Ayers, & Robert M. Carey. (1980). Antihypertensive Effects of Angiotensin Blockade: Saralasin Versus Captopril. PubMed. 2(6). 947–954. 8 indexed citations
14.
Johns, D W, Kenneth M. Baker, C R Ayers, et al.. (1980). Acute and chronic effect of captropril in hypertensive patients.. Hypertension. 2(4). 567–575. 26 indexed citations
15.
Baker, Kenneth M., D W Johns, C R Ayers, & Robert M. Carey. (1980). Ischemic cardiovascular complications concurrent with administration of captopril. A clinical note.. Hypertension. 2(1). 73–74. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026